Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate

By Chen H.   Subbarao K.   Swayne D.   Chen Q.   Lu X.   Katz J.   Cox N.   Matsuoka Y.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 1983-1988

Elsevier

Access to resources Recommend Favorite

Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects

By Treanor J.J.   Betts R.F.  

Vaccine, Vol. 16, Iss. 18, 1998-11 ,pp. : 1756-1760

Elsevier

Access to resources Recommend Favorite

Rapid identification of Newcastle disease virus vaccine strains LaSota and B-1 by restriction site analysis of their matrix gene

By Wehmann E.   Herczeg J.   Ballagi-Pordany A.   Lomniczi B.  

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1430-1433

Elsevier

Access to resources Recommend Favorite

Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium

By Voeten J.T.M.   Brands R.   Palache A.M.   van Scharrenburg G.J.M.   Rimmelzwaan G.F.   Osterhaus A.D.M.E.   Claas E.C.J.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1942-1950

Elsevier

Access to resources Recommend Favorite

Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly

By de Bruijn I.A.   Remarque E.J.   Beyer W.E.P.   le Cessie S.   Masurel N.   Ligthart G.J.  

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1323-1329

Elsevier

Access to resources Recommend Favorite